RICHMOND, Va., May 9, 2026 /PRNewswire/ -- NIRSense, Inc. today announced its participation in Balikatan-26, supporting the US Army Pacific (USARPAC)'s 18th Theater Medical Command (18th TMC) as they evaluate advanced approaches to battlefield casualty assessment using portable tissue oxygen saturation (StO₂) monitoring. Continue Reading Dr. Robert Furberg, center, explains operation of a care delivery platform software system and NIRSense Aegis X0 wireless data transmitter to U.S. Airmen during

BASEL, Switzerland, May 9, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficient drug discovery and development. As essential tools for innovative drug R&D, functional cell lines need clear, accessible usage authorization to keep projects on track. The updated policy expands authori

New data demonstrates ULTRApulse Alpha® CO2 effectiveness on patients with rhinophyma E‑poster highlights improved skin appearance and lesion clearance outcomes achieved with enhanced Stellar M22™ XPL technology Non-ablative Fractional 1565nm Laser Data supports FoLix™ efficacy in treating patients living with androgenic alopecia YOKNEAM, Israel, May 9, 2026 /PRNewswire/ -- Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced new clin

Welcome back to another edition of Endpoints Weekly! Earnings season is in full swing, but we had plenty of original reporting and exclusives you won’t find anywhere else this week. Chief among them: Andrew Dunn’s excellent story Friday on why biopharma is struggling to recruit young AI talent . Spoiler — it’s not just the pay gap with companies like OpenAI, though that’s definitely part of it. We also hosted a Post-Hoc Live recapping what we’ve seen in earnings so far, where I joined Drew Armst

ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on diabetes, obesity, non-alcoholic steatohepatitis (NASH), and related metabolic diseases, has announced the appointment of Michelle Mazuranic, PhD, MSM, RD, as Vice President of Medical and Regulatory Affairs. In this role, she oversees ProSciento’s medical affairs and regulatory consulting services, as well as works with clients to build strategic clinical development programs from early engagement assessme

ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro Invitational XVI Conference being held at the Luxe Sunset Boulevard hotel in Los Angeles, CA. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day. LD Micro Invitational XVI Conference Details: Date: Monday, May 18, 2026

ProSciento is proud to support the clinical research and development activities of Hanmi Pharmaceuticals and congratulate Hanmi and Sanofi on their partnership to develop therapeutics addressing diabetes. The licensing agreement announced by Sanofi and Hanmi Pharmaceuticals represents the intent to develop and commercialize Hanmi’s portfolio of three long-acting GLP-1 agonist and basal insulin candidates, including efpeglenatide, a phase 2b GLP-1 agonist with the potential for once-weekly to onc

Scientists may have found a smarter, safer way to wipe out termites hiding inside homes. A chemical called bistrifluron prevents drywood termites from forming new exoskeletons during molting, killing entire colonies from within. In tests, it eliminated about 95% of termites while avoiding the toxic side effects of traditional fumigation. Researchers say the method could provide longer-lasting protection as termites spread into new areas.Drywood termites are experts at staying out of sight. They

Scientists studying axolotls, zebrafish, and mice have uncovered a shared set of genes that may one day help humans regrow lost limbs. By identifying powerful “SP genes” involved in regeneration, researchers discovered that disabling these genes stopped proper bone regrowth in salamanders and mice. They then used a gene therapy inspired by zebrafish biology to partially restore regeneration in mice, marking a major step toward future treatments that could replace damaged limbs with living tissue

Rebooting the gut microbiome with bacteria from youth may help stop aging-related liver damage and even prevent liver cancer, according to new research in mice. Older mice that received their own preserved youthful microbiome showed less inflammation, reduced DNA damage, and no signs of liver cancer. Researchers also found that the treatment suppressed a cancer-linked gene called MDM2, making older mice biologically resemble younger ones.Scientists may have discovered a powerful new link between